Gilead Sciences Inc. (GILD) Financials Nov 20, 201
Post# of 250602
Posted On: 11/20/2014 8:35:09 PM
Gilead Sciences Inc. (GILD) Financials Nov 20, 2014, 7:59 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Gilead Sciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 6.93B 7.88B 8.46B 9.61B 11.22B
Cost of Goods Sold (COGS) incl. D&A 1.6B 1.87B 2.12B 2.47B 2.9B
COGS excluding D&A 1.38B 1.6B 1.82B 2.19B 2.55B
Depreciation & Amortization Expense 212.94M 265.48M 302.23M 278.21M 344.7M
Depreciation 64.56M 67.24M 72.19M 82.85M 102.64M
Amortization of Intangibles 148.38M 198.24M 230.05M 195.36M 242.06M
Gross Income 5.33B 6.01B 6.34B 7.14B 8.32B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.83B 2.09B 2.47B 3.22B 3.72B
Research & Development 914.22M 1.06B 1.23B 1.76B 2.12B
Other SG&A 912.09M 1.03B 1.24B 1.46B 1.6B
Other Operating Expense 0 0 0 0 0
Unusual Expense (9.41M) (115.36M) 56.56M 1.1M 74.85M
EBIT after Unusual Expense 9.41M 115.36M (56.56M) (1.1M) (74.85M)
Non Operating Income/Expense (29,000) (6.35M) 44.5M 52.63M (12M)
Non-Operating Interest Income 54.41M 0 0 0 0
Equity in Affiliates (Pretax) 0 - 0 - 0
Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Gross Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Interest Capitalized 0 0 0 0 -
Pretax Income 3.5B 3.91B 3.65B 3.61B 4.21B
Income Tax 876.36M 1.02B 861.95M 1.04B 1.15B
Income Tax - Current Domestic 873.15M 992.64M 767.04M 1.05B 1.22B
Income Tax - Current Foreign 42.86M 43.09M 39.92M 28.62M 45.54M
Income Tax - Deferred Domestic (38.46M) (12.39M) 50.94M (40.5M) (93.58M)
Income Tax - Deferred Foreign (1.19M) 454,000 4.04M (2.19M) (19.8M)
Income Tax Credits 0 - 0 - 0
Equity in Affiliates 0 - 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 2.63B 2.89B 2.79B 2.57B 3.06B
Minority Interest Expense (10.16M) (11.51M) (14.58M) (17.97M) (17.52M)
Net Income 2.64B 2.9B 2.8B 2.59B 3.07B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 2.64B 2.9B 2.8B 2.59B 3.07B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 2.64B 2.9B 2.8B 2.59B 3.07B
EPS (Basic) 1.46 1.70 1.81 1.71 2.01
Basic Shares Outstanding 1.81B 1.71B 1.55B 1.51B 1.53B
EPS (Diluted) 1.41 1.66 1.78 1.64 1.81
Diluted Shares Outstanding 1.87B 1.75B 1.58B 1.58B 1.69B
EBITDA 3.72B 4.18B 4.17B 4.2B 4.95B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Gilead Sciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 6.93B 7.88B 8.46B 9.61B 11.22B
Cost of Goods Sold (COGS) incl. D&A 1.6B 1.87B 2.12B 2.47B 2.9B
COGS excluding D&A 1.38B 1.6B 1.82B 2.19B 2.55B
Depreciation & Amortization Expense 212.94M 265.48M 302.23M 278.21M 344.7M
Depreciation 64.56M 67.24M 72.19M 82.85M 102.64M
Amortization of Intangibles 148.38M 198.24M 230.05M 195.36M 242.06M
Gross Income 5.33B 6.01B 6.34B 7.14B 8.32B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.83B 2.09B 2.47B 3.22B 3.72B
Research & Development 914.22M 1.06B 1.23B 1.76B 2.12B
Other SG&A 912.09M 1.03B 1.24B 1.46B 1.6B
Other Operating Expense 0 0 0 0 0
Unusual Expense (9.41M) (115.36M) 56.56M 1.1M 74.85M
EBIT after Unusual Expense 9.41M 115.36M (56.56M) (1.1M) (74.85M)
Non Operating Income/Expense (29,000) (6.35M) 44.5M 52.63M (12M)
Non-Operating Interest Income 54.41M 0 0 0 0
Equity in Affiliates (Pretax) 0 - 0 - 0
Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Gross Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Interest Capitalized 0 0 0 0 -
Pretax Income 3.5B 3.91B 3.65B 3.61B 4.21B
Income Tax 876.36M 1.02B 861.95M 1.04B 1.15B
Income Tax - Current Domestic 873.15M 992.64M 767.04M 1.05B 1.22B
Income Tax - Current Foreign 42.86M 43.09M 39.92M 28.62M 45.54M
Income Tax - Deferred Domestic (38.46M) (12.39M) 50.94M (40.5M) (93.58M)
Income Tax - Deferred Foreign (1.19M) 454,000 4.04M (2.19M) (19.8M)
Income Tax Credits 0 - 0 - 0
Equity in Affiliates 0 - 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 2.63B 2.89B 2.79B 2.57B 3.06B
Minority Interest Expense (10.16M) (11.51M) (14.58M) (17.97M) (17.52M)
Net Income 2.64B 2.9B 2.8B 2.59B 3.07B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 2.64B 2.9B 2.8B 2.59B 3.07B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 2.64B 2.9B 2.8B 2.59B 3.07B
EPS (Basic) 1.46 1.70 1.81 1.71 2.01
Basic Shares Outstanding 1.81B 1.71B 1.55B 1.51B 1.53B
EPS (Diluted) 1.41 1.66 1.78 1.64 1.81
Diluted Shares Outstanding 1.87B 1.75B 1.58B 1.58B 1.69B
EBITDA 3.72B 4.18B 4.17B 4.2B 4.95B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼